Clinical Trials
4 trialsNCT04700124 2026-02-05
KEYNOTE-B15
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03924856 2025-08-28
KEYNOTE-866
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03924895 2025-08-28
KEYNOTE-905
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT00003824 2012-03-09
S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
SWOG Cancer Research Network
Phase 3 Terminated